TrialBMJ open ophthalmology2024

Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in neovascular age-related macular degeneration (nAMD).

Parth Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.